4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-18-021463
Chief Financial Officer bought 300 shares at $6.72 ($2,016)
- Chief Financial Officer acquired 2,500 shares (grant or award)
- Chief Financial Officer gave up 843 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonner Michael Chief Financial Officer | 2018-03-19 | Purchase | +300 | $6.72 | $2,016 | 15,997 | D |
| Bonner Michael Chief Financial Officer | 2018-03-23 | Grant or award | +2,500 | $6.70 | $16,750 | 18,497 | D |
| Bonner Michael Chief Financial Officer | 2018-03-23 | Shares withheld for taxes | −843 | $6.70 | $5,648 | 17,654 | D |
| Open-market purchases · 300 sh · avg $6.72 · $2,016 | |||||||
Loading xslF345X03/doc4.xml…